Endometrial carcinoma: paraaortic dissemination

被引:104
作者
Mariani, A
Keeney, GL
Aletti, G
Webb, MJ
Haddock, MG
Podratz, KC
机构
[1] Mayo Clin, Sect Gynecol Surg, Rochester, MN 55905 USA
[2] Mayo Clin, Div Anat Pathol, Rochester, MN 55905 USA
[3] Univ Milan, Dept Math, Milan, Italy
[4] Mayo Clin, Div Radiat Oncol, Rochester, MN 55905 USA
关键词
adjuvant therapy; endometrial cancer; extended-field radiotherapy; lymphovascular invasion; myometrial invasion; paraaortic lymphadenectomy; paraaortic failure; positive lymph nodes;
D O I
10.1016/j.ygyno.2003.11.032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The objective of our study was to identify pathologic factors predictive of tumor dissemination to paraaortic lymph nodes (LNs) in endometrial carcinoma. The identification of the risk factors may potentially facilitate selection of patients for radical surgery or radiotherapy directed to the paraaortic area (PAA). Methods. The study population was a cohort from 612 consecutive patients with endometrial cancer surgically managed at our institution over a 10-year period. Tumor dissemination to the PAA was identified by selecting those patients who had either paraaortic LNs positive for disease at the time of primary surgery or those who subsequently experienced paraaortic failure or both (n = 41; the "PA mets" subgroup). Therefore, patients for whom no information was available about the status of paraaortic LNs but who had received adjuvant irradiation to the PAA and those for whom information was not available about sites of recurrent disease were excluded from the analysis, leaving 566 patients to compose the study population. Results. On the basis of univariate analysis, numerous pathologic variables were significantly (P less than or equal to 5 0.01) associated with PA mets. However, logistic regression analysis identified only two independent factors predictive of PA mets: positive pelvic LNs (P < 0.001, OR = 5.00) and lymphovascular invasion (LVI) (P = 0.01, OR = 1.99). Notably, only 2% of patients with negative pelvic LNs had PA mets compared with 47% of those with positive pelvic LNs (P < 0.001). When both pelvic LNs and LVI were negative, only 0.8% of the patients had PA mets compared with 3 1 % of patients for whom at least one of the two variables was positive (P < 0.001). Conclusion. Positive pelvic LNs and LVI identify a subgroup of high-risk patients (approximately one sixth of the overall population) who potentially may benefit from formal lymphadenectomy or adjuvant therapy or both directed to the PAA. Furthermore, with 47% of patients with positive pelvic LNs having PA mets, unstaged patients at risk for pelvic LN involvement should be considered candidates for both pelvic and paraaortic external beam radiotherapy or surgical restaging. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:833 / 838
页数:6
相关论文
共 34 条
[1]  
Announcements, 1989, Gynecologic Oncology, V35, P125, DOI [DOI 10.1016/0090-8258(89)90027-9, 10.1016/0090-8258(89)90027-9]
[2]   TUMOR STATUS OF LYMPH-NODES IN EARLY ENDOMETRIAL CANCER IN RELATION TO LYMPH-NODE SIZE [J].
AYHAN, A ;
TUNCER, ZS ;
TUNCER, R ;
YUCE, K ;
KUCUKALI, T .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1995, 60 (01) :61-63
[3]   Complete surgical staging of early endometrial adenocarcinoma: Optimizing patient outcomes [J].
Barnes, MN ;
Kilgore, LC .
SEMINARS IN RADIATION ONCOLOGY, 2000, 10 (01) :3-7
[4]   CLINICAL STAGE-I ADENOCARCINOMA OF THE ENDOMETRIUM - ANALYSIS OF RECURRENCES AND THE POTENTIAL BENEFIT OF STAGING LYMPHADENECTOMY [J].
BELINSON, JL ;
LEE, KR ;
BADGER, GJ ;
PRETORIUS, RG ;
JARRELL, MA .
GYNECOLOGIC ONCOLOGY, 1992, 44 (01) :17-23
[5]   Lymphadenectomy in high risk endometrial carcinoma stage I and II:: no more morbidity and no need for external pelvic radiation [J].
Berclaz, G ;
Hänggi, W ;
Kratzer-Berger, A ;
Altermatt, HJ ;
Greiner, RH ;
Dreher, E .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1999, 9 (04) :322-328
[6]   Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: Results of a pilot study [J].
Burke, TW ;
Levenback, C ;
Tornos, C ;
Morris, M ;
Wharton, JT ;
Gershenson, DM .
GYNECOLOGIC ONCOLOGY, 1996, 62 (02) :169-173
[7]  
CLIBY WA, 1995, J GYNECOL TECH, V1, P19
[8]  
CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO
[9]  
2-8
[10]   Surgical staging and high dose rate brachytherapy for endometrial cancer: Limiting external radiotherapy to node-positive tumors [J].
Fanning, J ;
Nanavati, PJ ;
Hilgers, RD .
OBSTETRICS AND GYNECOLOGY, 1996, 87 (06) :1041-1044